NanoMab Information

View Top Employees from NanoMab

NanoMab Technology Limited is a privately held biopharmaceutical company in the development of next generation cancer precision medicine. We are developing medicine for fast and specific delivery of radiation to treat cancer. A therapeutic product is made by a camelid antibody labelled with a radioisotope of therapeutic radiation. This therapeutic product is paired with a diagnosis, using the same antibody vector but labelled with a lower radiation radioisotope for imaging. Our goal is to develop a pipeline of therapeutic and diagnostic pairs, using our proprietary platform of camelid antibodies and of labelling radioisotopes onto the antibodies.

Website	http://www.nano-mab.com
Revenue	$6 million
Employees	7 (2 on RocketReach)
Founded	2016
Phone	+86 21 6229 9192
Industry	Pharmaceutical Manufacturing, Manufacturing General, Manufacturing
Keywords	Cancer Therapeutics, Cancer Treatment, Precision Medicine, Radiotherapy, Next Generation Medicine, Antibody Drug Conjugates, Targeted Drug Delivery, Innovative Cancer Therapies, Radiation Therapy, Nanomedicine, Immunotherapy, Oncology, Cancer Research, Targeted Therapies, Drug Development, Cancer Diagnostics, Clinical Trials, Pharmaceutical Research, Molecular Medicine
Competitors	abcam, Mabtech, Thermo Fisher Scientific, R&D Systems, Bio-Techne, Miltenyi Biotec, Roche, Cell Signaling Technology (CST), SAB Biotherapeutics , Inc., GenScript +44 more (view full list)
SIC	SIC Code 283 Companies, SIC Code 28 Companies
NAICS	NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies